114 related articles for article (PubMed ID: 1823734)
1. [Hospital risk factors in subclavian-pulmonary anastomosis with polytetrafluoroethylene graft].
Sant'Anna JR; Thomé LG; Lucchese FA; Kalil RA; Prates PR; Pereira E; Zielinzky P; Rossi R; Nesralla IA
Arq Bras Cardiol; 1991 May; 56(5):363-6. PubMed ID: 1823734
[TBL] [Abstract][Full Text] [Related]
2. [Use of PTFE (Gore-Tex) in pulmonary systemic anastomoses. Apropos of 50 cases].
Belhaj M; Binet JP; Langlois J; Planché C; Hvass U; Hafez A; Touchot-Kone A; Bruniaux J
Arch Mal Coeur Vaiss; 1983 May; 76(5):584-90. PubMed ID: 6411032
[TBL] [Abstract][Full Text] [Related]
3. Systemic-pulmonary artery shunt using PTFE prosthesis (Gore-Tex). Early results and long-term follow-up on 105 consecutive cases.
Di Benedetto G; Tiraboschi R; Vanini V; Annecchino P; Aiazzi L; Caprioli C; Parenzan L
Thorac Cardiovasc Surg; 1981 Jun; 29(3):143-7. PubMed ID: 6167011
[TBL] [Abstract][Full Text] [Related]
4. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.
de Leval MR; McKay R; Jones M; Stark J; Macartney FJ
J Thorac Cardiovasc Surg; 1981 Jan; 81(1):112-9. PubMed ID: 6450303
[TBL] [Abstract][Full Text] [Related]
5. Polytetrafluoroethylene shunts in congenital heart disease.
Nanton MA; Roy DL; Murphy DM; Finley JP; Lau H; Gillis DA; Murphy DA
Can J Surg; 1982 Mar; 25(2):134-8. PubMed ID: 7066772
[TBL] [Abstract][Full Text] [Related]
6. Experience with PTFE-prostheses for construction of Blalock-Taussig shunts.
Rigler B; Metzler H; Beitzke A; Stenzl W; Rehak P; Kraft-Kinz J
Life Support Syst; 1983; 1 Suppl 1():394-5. PubMed ID: 6086034
[No Abstract] [Full Text] [Related]
7. Modified Blalock-Taussig shunt in newborn infants.
Ilbawi MN; Grieco J; DeLeon SY; Idriss FS; Muster AJ; Berry TE; Klich J
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):770-5. PubMed ID: 6492843
[TBL] [Abstract][Full Text] [Related]
8. [Use of expanded polytetrafluoroethylene conduits in the construction of palliative fistulas in children].
Gómez-Ullate JM; Llamas P; Caffarena JM
Rev Esp Cardiol; 1983; 36(1):49-53. PubMed ID: 6878809
[No Abstract] [Full Text] [Related]
9. Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates.
Ahmad U; Fatimi SH; Naqvi I; Atiq M; Moizuddin SS; Sheikh KB; Shahbuddin S; Naseem TM; Javed MA
Heart Lung Circ; 2008 Feb; 17(1):54-8. PubMed ID: 17683985
[TBL] [Abstract][Full Text] [Related]
10. Systemic-pulmonary shunts in infants and children. Early and late results.
Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
[TBL] [Abstract][Full Text] [Related]
11. The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE).
Lawless CE; Smith EE; Hallidie-Smith K; Sapsford RN
J Cardiovasc Surg (Torino); 1982; 23(4):287-92. PubMed ID: 7107686
[TBL] [Abstract][Full Text] [Related]
12. [Modified Blalock-Taussig shunt using expanded polytetrafluoroethylene graft for cyanotic heart diseases in infants].
Yamaguchi T; Ito T; Watanabe N; Inao M; Kashino R
Kyobu Geka; 1983 Dec; 36(12):983-6. PubMed ID: 6672400
[No Abstract] [Full Text] [Related]
13. [Systemic-pulmonary anastomosis with a homologous umbilical vein graft in the palliative treatment of congenital heart disease with decreased pulmonary flow].
Cueva CN; Leão LE; Carvalho AC; Branco JN; Succi JE; Silva EE; Andrade JC; Buffolo E; Gallucci C
Arq Bras Cardiol; 1985 Jan; 44(1):27-30. PubMed ID: 2415090
[No Abstract] [Full Text] [Related]
14. [Systemic-pulmonary shunts in congenital heart diseases with decreased pulmonary blood flow: critical analysis of the surgical techniques and immediate results].
Maluf M; Andrade JC; Catani R; Carvalho AC; Lima WC; Andrade JL; Leão LE; Buffolo E
Arq Bras Cardiol; 1991 Apr; 56(4):281-6. PubMed ID: 1888301
[TBL] [Abstract][Full Text] [Related]
15. Outcome in infants less than 3 kilograms for placement of saphenous venous homografts as systemic-to-pulmonary arterial shunts.
Erez E; Bush D; Tam VK; Doublin NA; Stakes J
Cardiol Young; 2008 Aug; 18(4):386-91. PubMed ID: 18533068
[TBL] [Abstract][Full Text] [Related]
16. Modified blalock-taussig shunt in neonates.
Soueidi A; El-Rassi I
Heart Lung Circ; 2009 Feb; 18(1):62. PubMed ID: 18718814
[No Abstract] [Full Text] [Related]
17. Modified blalock-taussig shunt in neonates.
Talwar S; Choudhary SK; Airan B
Heart Lung Circ; 2009 Feb; 18(1):62-3. PubMed ID: 18534906
[No Abstract] [Full Text] [Related]
18. Outcome of the construction of a Blalock-Taussig shunt in adolescents and adults.
Peries A; Al-Hay AA; Shinebourne EA
Cardiol Young; 2005 Aug; 15(4):368-72. PubMed ID: 16014183
[TBL] [Abstract][Full Text] [Related]
19. [Systemic-pulmonary artery shunts using expanded polytetrafluoroethylene (EPTFE) grafts].
Gohda T; Sakuma M; Matsunami O; Yasuda K; Sakai K; Tanabe T; Murakami T
Nihon Kyobu Geka Gakkai Zasshi; 1985 Mar; 33(3):271-6. PubMed ID: 4020169
[No Abstract] [Full Text] [Related]
20. The Blalock-Taussig shunt. Low risk, effective palliation, and pulmonary artery growth.
Guyton RA; Owens JE; Waumett JD; Dooley KJ; Hatcher CR; Williams WH
J Thorac Cardiovasc Surg; 1983 Jun; 85(6):917-22. PubMed ID: 6190047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
